Direct medical cost of newly diagnosed stable coronary artery disease in Hong Kong

摘要: Background Stable coronary artery disease (CAD) affects approximately 7% of the population Hong Kong and is associated with substantial healthcare costs. Objective We aimed to evaluate first-year direct medical cost for a patient newly diagnosed stable CAD at tertiary care public hospital in identify CAD-related resource consumption pattern among different subgroups. Methods 89 consecutive patients our institution from January 2007 December 2009 were retrospectively analysed. Direct costs including hospitalisation, clinic visits, diagnostic tests, laboratory invasive procedures medications calculated 1 year after diagnosis. Mann-Whitney tests performed compare median without hypertension, diabetes mellitus hyperlipidaemia, undergoing intervention those who not. Results The mean total per was US$11 477. Hospitalisation dominant item accounting 29.2% cost. underwent procedure higher than treated medically alone (US$14 787 vs US$6121, p Conclusions Huge expenses are incurred first year diagnosis perspective local system. Healthcare highest hyperlipidaemia (even discounting procedural consumables). Strategies saving preventive measures should be implemented lower expenditure CAD.